Using a cardiovascular risk assessment tool developed based on NZ epidemiology, we can asses the risk of a CVD event over the next ❌ years.
Risk below %5 is considered low risk. Treatment and therapy has ❌ benefit. Risk is reassessed every 5-10 years.
Risk between 5-15% is considered moderate risk. Discussing the benefits of starting an anti-❌ medicine and ❌ with the patient. It will have a greater benefit the higher their ❌. Risk is reassessed every 2-5 years.
Risk over 15% is considered high risk. There is strong evidence to ❌ using anti-hypertensives and statins to reduce CVD events and deaths. Risk is reassessed ❌.
A patient who has already had a CVD event is treated the same as those in the high risk category, and those under ❌ are also recommended to take aspirin.
At all stages, diet and weight management, smoking ❌, and a physically ❌ lifestyle are recommended.
Drag and drop to complete the text.
hypertensive
hypertensive
